IDEAYA Biosciences Inc
NASDAQ:IDYA

Watchlist Manager
IDEAYA Biosciences Inc Logo
IDEAYA Biosciences Inc
NASDAQ:IDYA
Watchlist
Price: 29.47 USD -3.35% Market Closed
Market Cap: 2.5B USD
Have any thoughts about
IDEAYA Biosciences Inc?
Write Note

IDEAYA Biosciences Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

IDEAYA Biosciences Inc
Operating Expenses Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
IDEAYA Biosciences Inc
NASDAQ:IDYA
Operating Expenses
-$228.7m
CAGR 3-Years
-46%
CAGR 5-Years
-40%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Operating Expenses
-$21.9B
CAGR 3-Years
-4%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Operating Expenses
-$11.2B
CAGR 3-Years
-3%
CAGR 5-Years
4%
CAGR 10-Years
-8%
Amgen Inc
NASDAQ:AMGN
Operating Expenses
-$13.4B
CAGR 3-Years
-8%
CAGR 5-Years
-8%
CAGR 10-Years
-4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Operating Expenses
-$4.9B
CAGR 3-Years
-10%
CAGR 5-Years
-16%
CAGR 10-Years
-15%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Operating Expenses
-$7.8B
CAGR 3-Years
-23%
CAGR 5-Years
-16%
CAGR 10-Years
-17%

See Also

What is IDEAYA Biosciences Inc's Operating Expenses?
Operating Expenses
-228.7m USD

Based on the financial report for Sep 30, 2024, IDEAYA Biosciences Inc's Operating Expenses amounts to -228.7m USD.

What is IDEAYA Biosciences Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-40%

Over the last year, the Operating Expenses growth was -61%. The average annual Operating Expenses growth rates for IDEAYA Biosciences Inc have been -46% over the past three years , -40% over the past five years .

Back to Top